Improvement in Plasma Drug Activity during the Early Treatment Interval among Tanzanian Patients with Multidrug-Resistant Tuberculosis

BACKGROUND: Individual pharmacokinetic variability may be common in patients treated for multidrug-resistant tuberculosis (MDR-TB) but data are sparse from resource-limited settings and across the early treatment interval. METHODS: Plasma drug activity, as measured by the TB Drug Activity (TDA) assa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndusilo, Norah D., Heysell, Scott K., Mpagama, Stellah G., Gratz, Jean, Segesela, Farida H., Pazia, Saumu J., Wang, Xin-Qun, Houpt, Eric R., Kibiki, Gibson S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376785/
https://www.ncbi.nlm.nih.gov/pubmed/25816161
http://dx.doi.org/10.1371/journal.pone.0122769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376785/
https://www.ncbi.nlm.nih.gov/pubmed/25816161
http://dx.doi.org/10.1371/journal.pone.0122769

Ejemplares similares